Latest updates for Ms Relapse

Fresh curated links around MS relapse are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Scientists build mathematical model to track MS relapse patterns
  • Do nothing neuros maybe harming your brains
  • Blood test may help doctors spot MS relapses sooner, study shows

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiplesclerosisnewstoday.com /3 weeks ago

Scientists build mathematical model to track MS relapse patterns

A trio of scientists in Australia has developed a mathematical model that can be used to help understand disease activity patterns in people with multiple sclerosis (MS). The model...

Read source
multiple-sclerosis-research.org /1 month ago

Do nothing neuros maybe harming your brains

Daruwalla et al. Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis. Brain. 2026 Jul 24:awag252. Clinically silent MRI lesions occur...

Read source
multiplesclerosisnewstoday.com /1 month ago

Blood test may help doctors spot MS relapses sooner, study shows

A test using data from 18 blood biomarkers to track disease activity in multiple sclerosis (MS) was able to distinguish true MS relapses from symptom worsening unrelated to active...

Read source
multiplesclerosisnewstoday.com /1 week ago

Scientists link early relapsing MS to subtle changes in brain white matter

A trio of European scientists has linked subtle changes in the brain’s white matter — tissue rich in nerve cell projections — to early relapsing-remitting multiple sclerosis (RRMS)...

Read source
multiplesclerosisnewstoday.com /1 week ago

Experimental MS drug bests approved therapy in cutting relapses in 2 trials

An experimental oral drug called remibrutinib outperformed the approved therapy Aubagio (teriflunomide) in reducing disease flare rates in two large, late-stage clinical trials inv...

Read source
multiplesclerosisnewstoday.com /1 month ago

FDA feedback supports new testing path for therapy in MS relapses

After receiving positive regulatory feedback from the U.S. Food and Drug Administration (FDA), Oculis is planning to expand clinical testing of its experimental therapy privosegtor...

Read source
multiplesclerosisnewstoday.com /1 month ago

2 brain MRI markers may help ID MS patients at risk of cognitive decline

In analyzing brain MRIs on people with early relapsing-remitting multiple sclerosis (RRMS), two markers of ongoing inflammation may help identify those patients at a higher risk of...

Read source
multiplesclerosisnewstoday.com /3 weeks ago

One silent MRI lesion may be enough to consider stronger MS treatment

People with relapsing-remitting multiple sclerosis (RRMS) who show even a single silent lesion on an MRI scan while taking a lower- or moderate-efficacy disease-modifying therapy (...

Read source
multiple-sclerosis-research.org /1 month ago

Learning about what could happen in MS by looking at other conditions

In MS we do not know of a definative target. But in neuromyelitis optic a demyelinating condition of the spinal cord and optic nerves is associated with antibodies against a water...

Read source
multiplesclerosisnewstoday.com /1 week ago

Study review finds inconsistent evidence for vitamin D in MS care

Vitamin D supplementation did not consistently reduce relapse rates in adults with multiple sclerosis (MS), although it may reduce the number of MS lesions seen on MRI scans, accor...

Read source
multiplesclerosisnewstoday.com /1 month ago

Learning new skills could promote myelin repair in MS patients

Rehabilitation strategies aimed at learning new skills may promote myelin repair in people with multiple sclerosis (MS), said scientists, who called for more research to test these...

Read source
multiplesclerosisnewstoday.com /2 weeks ago

Early high-efficacy MS drugs cut relapse risk, not progression

Early treatment with high-efficacy disease-modifying therapies (DMTs) lowered the risk of relapse-associated disability progression in people with multiple sclerosis (MS), but had...

Read source
multiple-sclerosis-research.org /2 weeks ago

CD20 is an IRT when will they twig?

Maal AB, Arki MK, Nabavi SM, Rezaei-Tavirani M, Rismani E, Vosough M, Azizi G, Hossein-Khannazer N. Immune reconstitution and tolerance-inducing therapies as promising therapeutic...

Read source
refractor.io /1 month ago

Criteria for MS have changed. Here’s what leading experts now outline

Two years ago, the list of signs and symptoms required to diagnose a patient with the neurodegenerative autoimmune disease multiple sclerosis underwent a massive overhaul.Continue...

Read source
multiple-sclerosis-research.org /1 month ago

Stopping treatment with an anti-relapse agent in progressive MS. What does it tell us?

Ocrelizumab is licenced for relapsing and active primary progressive MS (Lesions and relapses) in the EU…It is active because we know it works by stopping B cells from entering the...

Read source
multiple-sclerosis-research.org /2 weeks ago

Different PIRA, different results

So I have been banging on about PIRA being a measure that incorporates the action of anti-inflammatory treatment and here the info says that high efficacy treatment inhibits relaps...

Read source
multiple-sclerosis-research.org /1 week ago

Lesions and disability in MS are (partially) disconnected

Controversy about the significance of lesions (inflammation) versus other (neurodegenerative) factors for the evolution and degree of disability in MS continues. Here, we have a gr...

Read source
multiplesclerosisnewstoday.com /1 day ago

Relapsing-remitting MS patients may have less diverse gut bacteria

People with relapsing-remitting multiple sclerosis (MS) may have less diverse gut bacteria than healthy people, with shifts in genes involved in how well certain bacteria break thr...

Read source
multiple-sclerosis-research.org /6 days ago

Diagnosing MS early, accurately & efficiently

A little while ago, the new “McDonald” criteria were published. Here are our thoughts about the potential of moving the needle towards earlier detection, the risk of not getting it...

Read source
multiple-sclerosis-research.org /1 month ago

B cell repopulation is consistent following depletion

Hogenboom et al. Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab. Eur J Neurol. 2026; 33:...

Read source
multiple-sclerosis-research.org /4 weeks ago

Magnifying Cladribine in year 3-4

ProfK has ben magnifying the cladribine natural history and they have got back to where we left off in 2010, when they threw cladribine out with the bath water. They say that cladr...

Read source
multiple-sclerosis-research.org /1 week ago

Where is the action of anti-CD20 and other antibodies on Neurodegeneration

Nerve damage is a consequence of poorly controlled MS and in one place it is easy to monitor nerve damage and this is in the eye. The eye is connected to your brain and nerve damag...

Read source
multiplesclerosisnewstoday.com /4 weeks ago

Blood protein marker may predict hidden MS progression

Elevated levels of a blood protein called GFAP are associated with an increased risk of disease progression in the absence of relapse activity in people with multiple sclerosis (MS...

Read source
multiplesclerosisnewstoday.com /5 days ago

New MS cell therapy safely retrains immune system to tolerate myelin

A new experimental cell therapy that pairs a patient’s own red blood cells with myelin protein fragments safely calmed the immune system and helped dampen the inflammatory attack t...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Ms Relapse

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source

newatlas.com

Recent coverage from public sources
Public source

Related searches

News Archive MS relapse MRI RRMS Experimental treatment disease progression myelin research Cognitive therapy Diagnosis of MS Disease modifying therapies (DMT)

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing